-
公开(公告)号:US20240294551A1
公开(公告)日:2024-09-05
申请号:US18614911
申请日:2024-03-25
Applicant: AMGEN INC.
Inventor: Ryan Paul Wurz , Yunxiao LI , Primali Vasundera NAVARATNE , Jose M. MEDINA , Ning CHEN , Liping PETTUS , Xiaofen LI , John STELLWAGEN , Kexue LI , Brian Alan LANMAN , Michael M. YAMANO , Wei ZHAO , Benjamin WIGMAN , Fabien EMMETIERE , Albert K. AMEGADZIE , Christopher P. MOHR , Aaron C. SIEGMUND , Rene RAHIMOFF , Zhichen WU , Adriano BAUER , Andrew SMALIGO , Quentin Tercenio , Qingyian Liu , Shon K. Booker
IPC: C07D519/00 , A61K31/519 , A61K31/5377 , A61K31/5383 , A61K31/55 , A61K31/551 , A61K31/553 , C07D471/22 , C07D498/22 , C07D513/22
CPC classification number: C07D519/00 , A61K31/519 , A61K31/5377 , A61K31/5383 , A61K31/55 , A61K31/551 , A61K31/553 , C07D471/22 , C07D498/22 , C07D513/22
Abstract: The present disclosure provides compounds useful for the inhibition of KRAS G12D, G12V, G12A, G12S, G13D, Q61H, Q61L or G12C. The compounds have a general Formula I′:
wherein the variables of Formula I′ are defined herein. This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, cancer.-
公开(公告)号:US20240409557A1
公开(公告)日:2024-12-12
申请号:US18657114
申请日:2024-05-07
Applicant: AMGEN INC.
Inventor: Kevin Lloyd GREENMAN , Alexander J. Pickrell , Kexue LI , Albert K. AMEGADZIE , Hui-Ling WANG , Nicholas Anthony WEIRES , John G. ALLEN , Matthew P. BOURBEAU
IPC: C07D519/00 , A61K31/437 , A61K31/519 , A61P1/04
Abstract: The present disclosure provides novel 15-hydroxy-prostaglandin dehydrogenase inhibitors, pharmaceutical compositions comprising such compounds, and methods of using such compounds and compositions in treating 15-hydroxy-prostaglandin dehydrogenase-mediated disease. Also provided are methods of making such compounds and intermediates thereof. The compounds have a general Formula (A). Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula (A).
-